MOA Biotech ApS: Financial statements 2025
CVR: 38844679
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MOA Biotech ApS (CVR 38844679) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -9,297 and a net result of DKK -9,297 compared with DKK -8,899 the year before. Equity in the 2025 report amounted to DKK 1,121. The solvency ratio was 12.3%.
- Gross Profit
- DKK -9,297
- Profit/Loss
- DKK -9,297
- Equity
- DKK 1,121
- Total Assets
- DKK 9,120
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -9 t. | -9 t. | 1 t. | 0 |
| 2024 | - | -9 t. | -9 t. | 10 t. | - |
| 2023 | - | -9 t. | -3 t. | 19 t. | - |
| 2022 | - | -7 t. | -17 t. | 23 t. | - |
| 2021 | - | -8 t. | -8 t. | 40 t. | - |
Official annual report
How creditworthy is MOA Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
MOA Biotech ApS has published its annual report for 2024. Gross profit came to DKK -8,928, and the net result was DKK -8,899.
About MOA Biotech ApS
MOA Biotech ApS is a Danish company of the type Anpartsselskab based in Odense S, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Morten Østergaard Andersen. The company is owned by Morten Østergaard Andersen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -9,297 and a net result of DKK -9,297 compared with DKK -8,899 the year before. Equity in the 2025 report amounted to DKK 1,121.